Financials
- Market Capitalization 11.33 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
40.64
Fiyat/satışlar oranı
3.42
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 816 | AXSM Axsome Therapeutics, Inc. - Common Stock | 235.26 USD | +3.06% | -5.65% | -7.75% | +80.69% | 12.11 B USD | ||
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.47 USD | +1.11% | -1.78% | +9.56% | -22.10% | 12.01 B USD | ||
| 856 | TECH Bio-Techne Corp - Common Stock | 71.23 USD | -0.18% | +0.82% | +26.27% | +37.03% | 11.15 B USD | ||
| 879 | ABVX Abivax SA - American Depositary Shares | 134.91 USD | -0.79% | -4.19% | +36.27% | +1246.41% | 10.60 B USD |